This inventor holds 1 USPTO granted patent. Top assignee: Amneal Pharmaceuticals LLC. Active years: 2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2016
Title: Patil Tushar Yashwant: Innovator in Pharmaceutical Chemistry
Introduction
Patil Tushar Yashwant is a notable inventor based in Maharashtra, India. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of processes for drug synthesis. His work is characterized by a focus on improving industrial feasibility and efficiency in pharmaceutical production.
Latest Patents
Patil holds a patent for a process for the preparation of saxagliptin and its hydrochloride salt. This patent describes an improved and industrially feasible method for synthesizing saxagliptin, a medication used to treat type 2 diabetes. The patent also details novel intermediates and their applications in the preparation of saxagliptin or its hydrochloride salt. He has 1 patent to his name, showcasing his innovative approach to pharmaceutical development.
Career Highlights
Patil Tushar Yashwant is currently employed at Amneal Pharmaceuticals LLC, a company known for its commitment to developing high-quality generic and specialty pharmaceuticals. His role involves research and development, where he applies his expertise in chemical processes to enhance drug formulation and production.
Collaborations
Throughout his career, Patil has collaborated with several professionals in the field. Notable coworkers include Patil Shashikant Prabhakarrao and Pansuriya Ketan Jahyantibhai, who have contributed to various projects alongside him.
Conclusion
Patil Tushar Yashwant exemplifies the spirit of innovation in the pharmaceutical industry. His contributions, particularly in the synthesis of saxagliptin, highlight the importance of research and development in creating effective medications. His work continues to impact the field positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
